Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by upside80on Feb 05, 2021 2:16pm
101 Views
Post# 32486127

RE:RE:RE:We are Due!!

RE:RE:RE:We are Due!!
oats wrote: Given that we are now a week into February Jenene, are we still deemed to be ahead of schedule, please see below in yellow.

Does the company expect to issue any form of update soon?  

Oh sorry, I know you can't answer that question due to "selective disclosure" issues.  Let me try this one:  Do you think we will see news in the within 180 days of the last real news release of October 22, 2020?  Damn, sorry Jenene, I keep coming up with these obvious "selective disclosure" questions.  Try this one:  Can you tell me what your most important task is going forward to further enhance the profile of Ceapro in both Canada and the US?  Did I cross the line on that question as well?

With the expected completion of the third and fourth goals related to tolerability, safety and efficacy studies with both nave and pre-clinical animal models as early as mid-October, our teams are positioning us to be ahead of schedule. 


You can only appreciate how funny this post is if you've called Jenene before, pure gold. 

<< Previous
Bullboard Posts
Next >>